Of note, the ITGA2 antibody conjugated on the liposome surface is not only a targeting ligand, but also has a therapeutic function itself: antibody blockade of ITGA2 on GBM cells potently inhibits GBM cell migration. Here, ITGA2 is linked to glioblastoma.